Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic DermatitisEric L. Simpson, Ashish Bansal, Jamie Weisman et al.|JAMA Dermatology|2019Cited by 505
Dupilumab in Adults and Adolescents with Eosinophilic EsophagitisEvan S. Dellon, Arsalan Shabbir, Marc E. Rothenberg et al.|New England Journal of Medicine|2022Cited by 452
Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trialAmy S. Paller, Brad Shumel, Elaine C. Siegfried et al.|Journal of the American Academy of Dermatology|2020Cited by 385
Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of AgeMirna Chehade, Jennifer Maloney, Evan S. Dellon et al.|New England Journal of Medicine|2024Cited by 107
Dupilumab as an Adjunct to Oral Immunotherapy in Pediatric Patients With Peanut AllergyR. Sharon Chinthrajah, Allen Radin, Sayantani Sindher et al.|Allergy|2024Cited by 33